Recent Advances in Multi-target Drugs Targeting Protein Kinases and Histone Deacetylases in Cancer Therapy.

导出原文传递

翻译打印收藏纠错

作者： Yong,Ling ^[1] ; Ji,Liu ^[1] ; Jianqiang,Qian ^[1] ; Chi,Meng ^[1] ; Jing,Guo ^[1] ; Weijie,Gao ^[1] ; Biao,Xiong ^[1] ; Changchun,Ling ^[2] ; Yanan,Zhang ^[1]

作者单位： School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong 226001, China. ^[1] The Affiliated Hospital of Nantong University, Nantong University, Nantong 226001, China. ^[2]

关键词 Anticancer agents combination therapy histone deacetylase inhibitor hybrids multi-target protein kinase inhibitor receptor tyrosine kinases

主题词抗肿瘤药(Antineoplastic Agents);组蛋白脱乙酰基酶抑制剂(Histone Deacetylase Inhibitors);组蛋白脱乙酰基酶类(Histone Deacetylases);人类(Humans);肿瘤(Neoplasms);药用制剂(Pharmaceutical Preparations);蛋白激酶类(Protein Kinases)

DOI 10.2174/0929867327666200102115720

PMID 31894740

发布时间 2021-08-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交